Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Innate Pharma SA/ 6-K

SEC Filing · 6-K

Innate Pharma SA

IPHYFOTCEQUITYCurrent

SEC Filing

Filed Aug 19, 2026Accepted Aug 19, 2026, 4:02 PM EDTCIK 1598599Accession 0001628280-26-057935
View company →Permanent SEC source ↗
Share

Company context

Current securities

IPHANASDAQ · ADR · CurrentIPHYFOTC · EQUITY · Current

Recent company filings

  1. 6-K filingSep 17, 2026
  2. 6-K filingSep 17, 2026
  3. 6-K filingSep 17, 2026
  4. 6-K filingSep 10, 2026
  5. 6-K filingSep 2, 2026

As-filed source

Primary evidence
As filedOpen full document ↗